OCULIS HOLDING AG (OCS)
Oculis Signs Asset Purchase Agreement with Accure Therapeutics for Lead Candidate, Privosegtor, Fortifying Oculis’ Position as an Emerging Leading Neuro-Ophthalmology Company
DIGITAL REALTY TRUST, INC. (DLR)
Ekstraordinære indfrielser (CK 93)
RP OPTICAL LAB LTD (RPOL)
Started to be an interested party - Migdal Insurance and Financial Holdings Ltd.
MEGA OR HOLDINGS LTD (MGOR)
Presentation to the capital market - second quarter of 2026
PRUDENTIAL PLC (K6S)
General Announcement: Transaction in own shares
PAYSAFE LIMITED COMMON SHARES (PSFE)
PaysafeWallet Is Now Live in Poland: Your Money, Your Way
ANCHUN INTERNATIONAL HOLDINGS LTD. (BTX)
Financial Statements and Related Announcement: Profit Guidance
OCULIS HOLDING AG (OCS)
Oculis Signs Asset Purchase Agreement with Accure Therapeutics for Lead Candidate, Privosegtor, Fortifying Oculis’ Position as an Emerging Leading Neuro-Ophthalmology Company
OCULIS HOLDING AG (OCS)
Oculis undirritar kaupsamning við Accure Therapeutics um leiðandi þróunarlyfið Privosegtor og eflir þannig stöðu Oculis sem leiðandi vaxtarfyrirtækis á sviði taugaaugnlækninga
ASE TECHNOLOGY HOLDING CO., LTD. (ASX)
ASE Technology Holding Co., Ltd. Announces Monthly Net Revenues*